Table 3. Comparison between SUAVe study and SUAVe-PEGASUS trial.
| SUAVe study | SUAVe-PEGASUS trial | ||
|---|---|---|---|
| Main results | Target aneurysms, n | 448 | 247 |
| Mean follow-up period, months | 42.5 | 32.4 | |
| Aneurysm growth, % | 6.7 | 18.2 | |
| Aneurysm rupture, % | 1.9 | 0 | |
| Risk factors | Female sex, % | 63.6 | 63.3 |
| Age, year | 61.9 ± 10.3 | 60.8 ± 8.7 | |
| Patients with multiple aneurysms, % | 33.2 | 47.4 | |
| Previous SAH, % | 9.6 | 7.6 | |
| Family history of SAH, % | 8.3 | 8.6 | |
| Hypertension, % | 24.9 | 40 | |
| Aneurysm location | MCA, % | 35.3 | 42.3 |
| ICA, % | 38.6 | 35.1 | |
| Acom, % | 13.4 | 8.9 | |
| ACA, % | 2.7 | 8.1 | |
| BA, % | 7.4 | 5.2 | |
| Others, % | 2.7 | 0.4 |
ACA: anterior carotid artery, Acom: anterior communicating artery, BA: basilar artery, ICA: internal carotid artery, MCA: middle cerebral artery, SAH: subarachnoid hemorrhage, SUAVe: small unruptured intracranial aneurysm verification.